CLSD - Clearside Biomedical appoints Chong as CMO
2024-03-18 13:56:57 ET
More on Clearside Biomedical
- Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript
- Clearside to sell 11.11M shares at $1.35 in registered direct offering
- Seeking Alpha’s Quant Rating on Clearside Biomedical
- Historical earnings data for Clearside Biomedical
- Financial information for Clearside Biomedical